Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of January 23, 2025, SCYNEXIS (SCYX) has a market cap of $40.220 million USD. According to our data, SCYNEXIS is ranked No.8278 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Jan 23, 2025 | $40.22 M |
-12.40%
|
| Dec 31, 2024 | $45.91 M |
-45.74%
|
| Dec 29, 2023 | $84.61 M |
42.95%
|
| Dec 30, 2022 | $59.19 M |
-74.43%
|
| Dec 31, 2021 | $0.23 B |
-20.26%
|
| Dec 31, 2020 | $0.29 B |
-15.93%
|
| Dec 31, 2019 | $0.35 B |
88.80%
|
| Dec 31, 2018 | $0.18 B |
-79.22%
|
| Dec 29, 2017 | $0.88 B |
-27.27%
|
| Dec 30, 2016 | $1.21 B |
-48.63%
|
| Dec 31, 2015 | $2.36 B |
-37.78%
|
| Dec 31, 2014 | $3.79 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
 Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
 Merck
MRK
|
$242.04 B |
-0.000 M
|
USA
|
 Johnson & Johnson
JNJ
|
$349.75 B |
0.001 M
|
USA
|
 Novartis
NVS
|
$196.27 B |
-0.007 M
|
Switzerland
|
 GlaxoSmithKline
GSK
|
$68.21 B |
-0.002 M
|
UK
|
 Bristol-Myers Squibb
BMY
|
$115.79 B |
-0.003 M
|
USA
|
 AbbVie
ABBV
|
$299.00 B |
-0.007 M
|
USA
|
 Eli Lilly
LLY
|
$678.07 B |
0.022 M
|
USA
|
 Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
 Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
 Teva Pharmaceutical Industries
TEVA
|
$24.96 B |
19.808 M
|
Israel
|
| Market Cap | = | SCYX Stock Price | * | SCYX Shares Outstanding |
| = | $1.06 | * | 37.94 M | |
| = | $40.22 M |